Anders Krarup-Hansen

Anders Krarup-Hansen

Clinical Associate Professor

Member of:

  • Clinical Oncology


  1. 2020
  2. Published

    Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients with Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial

    Tap, W. D., Wagner, A. J., Schöffski, P., Martin-Broto, J., Krarup-Hansen, A., Ganjoo, K. N., Yen, C. C., Abdul Razak, A. R., Spira, A., Kawai, A., Le Cesne, A., Van Tine, B. A., Naito, Y., Park, S. H., Fedenko, A., Pápai, Z., Soldatenkova, V., Shahir, A., Mo, G., Wright, J. & 2 others, Jones, R. L. & ANNOUNCE Investigators, A. I., 2020, In: J A M A: The Journal of the American Medical Association. 323, 13, p. 1266-1276 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Improved Survival of Children, Adolescents, and Young Adults With Head and Neck Soft Tissue Sarcomas in Denmark

    Mirian, C., Grønhøj, C., Rechnitzer, C., Charabi, Birgitte Wittenborg, Hjalgrim, L. L., Krarup-Hansen, Anders, von Buchwald, Christian & Hjuler, Thomas, 2020, In: Journal of Pediatric Hematology/Oncology. 42, 3, p. 175-180

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    In vitro 4-1BB stimulation promotes expansion of CD8+ tumor-infiltrating lymphocytes from various sarcoma subtypes

    Nielsen, M., Krarup-Hansen, Anders, Hovgaard, D., Petersen, Michael Mørk, Loya, Anand Chainsukh, Westergaard, M. C. W., Svane, Inge Marie & Junker, N., 2020, In: Cancer Immunology, Immunotherapy. 69, p. 2179-2191

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Pembrolizumab as first line treatment of Merkel cell carcinoma patients–a case series of patients with various co-morbidities

    Bystrup Boyles, T., Schødt, M., Hendel, Helle Westergren, Krarup-Hansen, Anders & Junker, N., 2020, In: Acta Oncologica. 59, 7, p. 793-796 4 p.

    Research output: Contribution to journalLetterResearchpeer-review

  6. 2021
  7. Published

    Benefit of pazopanib in advanced gastrointestinal stromal tumours: results from a phase II trial (SSG XXI, PAGIST)

    Eriksson, M., Reichardt, P., Joensuu, H., Krarup-Hansen, Anders, Hagberg, O., Hohenberger, P., Hagberg, H., Hansson, L., Foukakis, T., Pulkkanen, K., Bauer, S., Goplen, D., Blach Rossen, P. & Hall, K. S., 2021, In: ESMO Open. 6, 4, 6 p., 100217.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Outstanding Response to Sorafenib in a Patient with Metastatic Gastrointestinal Stromal Tumour

    Brinch, C., Dehnfeld, M., Høgdall, Estrid Vilma Solyom, Poulsen, T. S., Toxvaerd, A., Al-Farra, G., Bergenfeldt, M. & Krarup-Hansen, Anders, 5 Nov 2021, In: Case Reports in Oncology. 14, 3, p. 1567-1573 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. 2022
  10. Published

    Medical oncological treatment for patients with Gastrointestinal Stromal Tumor (GIST) – A systematic review

    Brinch, C. M., Aggerholm-Pedersen, N., Høgdall, Estrid Vilma Solyom & Krarup-Hansen, Anders, 2022, In: Critical Reviews in Oncology/Hematology. 172, 18 p., 103650.

    Research output: Contribution to journalReviewResearchpeer-review

  11. Published

    Pre-and Postoperative Circulating Tumour DNA in Patients with Gastrointestinal Stromal Tumour: A Methodological Assessment Study

    Brinch, C. M., Aggerholm-Pedersen, N., Poulsen, T. S., Skovrider-Ruminski, W., de Heer, P., Penninga, Luit, Krarup-Hansen, Anders & Høgdall, Estrid Vilma Solyom, 2022, In: Anticancer Research. 42, 11, p. 5527-5537

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Real-life incidence of cardiotoxicity and associated risk factors in sarcoma patients receiving doxorubicin

    Vitfell-Rasmussen, J., Krarup-Hansen, Anders, Vaage-Nilsen, M., Kümler, T. & Zerahn, B., 2022, In: Acta Oncologica. 61, 7, p. 801-808 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor

    Brinch, C. M., Høgdall, Estrid Vilma Solyom, Junker, N., Moeller, H. J., Sandfeld-Paulsen, B., de Heer, P., Penninga, Luit, Rossen, P. B., Krarup-Hansen, Anders & Aggerholm-Pedersen, N., 2022, In: Cancers. 14, 23, 5753.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 925763